PRB-2

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRB-2
Drug Alias NamePRB program (Pronova)PRB-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsInflammationMetabolic DiseasesCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPronova BioPharma ASA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPronova BioPharma ASA
Active IndicationsN/A
Inactive IndicationsInflammationMetabolic DiseasesCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A